- Home
- MDAI vs CRIS Comparison
MDAI vs CRIS Comparison
Compare MDAI & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- CRIS
- Stock Information
- Founded
- MDAI 2013
- CRIS 2000
- Country
- MDAI United States
- CRIS United States
- Employees
- MDAI N/A
- CRIS N/A
- Industry
- MDAI Medical/Dental Instruments
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MDAI Health Care
- CRIS Health Care
- Exchange
- MDAI Nasdaq
- CRIS Nasdaq
- Market Cap
- MDAI 27.8M
- CRIS 32.8M
- IPO Year
- MDAI N/A
- CRIS 2000
- Fundamental
- Price
- MDAI $1.18
- CRIS $1.28
- Analyst Decision
- MDAI Strong Buy
- CRIS Strong Buy
- Analyst Count
- MDAI 2
- CRIS 3
- Target Price
- MDAI $4.75
- CRIS $21.00
- AVG Volume (30 Days)
- MDAI 421.8K
- CRIS 56.3K
- Earning Date
- MDAI 05-06-2025
- CRIS 03-31-2025
- Dividend Yield
- MDAI N/A
- CRIS N/A
- EPS Growth
- MDAI N/A
- CRIS N/A
- EPS
- MDAI N/A
- CRIS N/A
- Revenue
- MDAI $29,581,000.00
- CRIS $10,908,000.00
- Revenue This Year
- MDAI N/A
- CRIS N/A
- Revenue Next Year
- MDAI $49.47
- CRIS $27.88
- P/E Ratio
- MDAI N/A
- CRIS N/A
- Revenue Growth
- MDAI 63.83
- CRIS 8.83
- 52 Week Low
- MDAI $0.82
- CRIS $1.33
- 52 Week High
- MDAI $3.25
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- MDAI 36.48
- CRIS 13.73
- Support Level
- MDAI $1.04
- CRIS $1.40
- Resistance Level
- MDAI $1.31
- CRIS $2.62
- Average True Range (ATR)
- MDAI 0.14
- CRIS 0.25
- MACD
- MDAI -0.01
- CRIS -0.13
- Stochastic Oscillator
- MDAI 22.49
- CRIS 0.29
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.